Powered by

Opioid maker Purdue also sought rehab profits

Jan 31, 2019 - The Boston Globe

Not content with billions of dollars in profits from OxyContin, its maker explored expanding into an "attractive market" fueled by the drug's popularity: the treatment of opioid addiction. That's according to previously secret passages in a court document filed by the Commonwealth of Massachusetts.

In internal correspondence beginning in 2014, Purdue Pharma executives discussed how the sale of opioids and the treatment of opioid addiction are "naturally linked" and that the company should ...